Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0043167 (
pertussis
)
19,595
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously reported that Gbetagamma signaling regulates cell spreading or cell shape change through activation of a Rho family small GTPase, suggesting the existence of a Gbetagamma-regulated Rho guanine-nucleotide exchange factor (RhoGEF). In this study we examined various RhoGEF clones, found
FLJ00018
to beaGbetagamma-activated RhoGEF, and investigated the molecular mechanism of Gbetagamma-induced activation of Rho family GTPases. Co-expression of the genes for
FLJ00018
and Gbetagamma enhanced serum response element-mediated gene transcription in HEK-293 cells. Combined expression of Gbetagamma and
FLJ00018
significantly induced activation of Rac and Cdc42 but not RhoA.
FLJ00018
also enhanced gene transcription induced by carbachol-stimulated m2 muscarinic acetylcholine receptor, and this enhancement was blocked by
pertussis
toxin. Furthermore, we demonstrated Gbetagamma to interact directly with the N-terminal region of
FLJ00018
and the N-terminal fragment of this molecule to inhibit serum response element-dependent transcription induced by Gbetagamma/
FLJ00018
and carbachol. In NIH3T3 cells,
FLJ00018
enhanced lysophosphatidic acid-induced cell spreading, which was also blocked by the N-terminal fragment of
FLJ00018
. These results provide evidence for a signaling pathway by which G(i)-coupled receptor specifically induces Rac and Cdc42 activation through direct interaction of Gbetagamma with
FLJ00018
.
...
PMID:Heterotrimeric G protein betagamma subunits stimulate FLJ00018, a guanine nucleotide exchange factor for Rac1 and Cdc42. 1804 77